AstraZeneca R&D Charnwood

AstraZeneca R&D Charnwood is one of AstraZeneca's nine worldwide research and development sites. Research work is focused on respiratory and inflammatory diseases with development capabilities for pharmaceutical and analytical R&D, process R&D, regulatory and clinical, which are used globally by the AstraZeneca R&D organisation.

AstraZeneca R&D Charnwood Based is based on a 70 acre site in Loughborough, Leicestershire with over 1,200 staff.

The site actively supports the many local organisations that give valuable services to the local community. The focus is on education, particularly science-based initiatives, improving the health and well being of the community and enabling staff to develop and share their skills with local groups.

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $18.8 billion and leading positions in sales of gastrointestinal, oncology, cardiovascular, neuroscience and respiratory products.

AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) and the FTSE4Good Index.

Achievements 

• Big Tick winner of Merrill Lynch Raising Achievement in Young People Award 2007 
• Gold in Business in the Community's Corporate Responsibility Index 2006
• Gold in Business in the Community's Environment Index 2006
• Silver in Business in the Community's Community Index 2006
• Big Tick winner of Merrill Lynch Investing in Young People Award 2006
• Simon Proffitt, Vice President and Site Manager, AstraZeneca R&D Charnwood, winner of the Prince's Ambassador for the East Midlands Award 2006
• 39th in Business in the Community's Corporate Responsibility Index 2005
• 48th in Business in the Community's Environment Index 2005
• Winner of East Midlands Sustainable Development Award 2005